Literature DB >> 25735931

Tumor suppressor candidate 3 (TUSC3) prevents the epithelial-to-mesenchymal transition and inhibits tumor growth by modulating the endoplasmic reticulum stress response in ovarian cancer cells.

Kateřina Kratochvílová1,2, Peter Horak3, Milan Ešner1, Karel Souček2,4,5, Dietmar Pils6, Mariam Anees3,7, Erwin Tomasich3, František Dráfi1, Veronika Jurtíková1, Aleš Hampl1, Michael Krainer3, Petr Vaňhara1.   

Abstract

Ovarian cancer is one of the most common malignancies in women and contributes greatly to cancer-related deaths. Tumor suppressor candidate 3 (TUSC3) is a putative tumor suppressor gene located at chromosomal region 8p22, which is often lost in epithelial cancers. Epigenetic silencing of TUSC3 has been associated with poor prognosis, and hypermethylation of its promoter provides an independent biomarker of overall and disease-free survival in ovarian cancer patients. TUSC3 is localized to the endoplasmic reticulum in an oligosaccharyl tranferase complex responsible for the N-glycosylation of proteins. However, the precise molecular role of TUSC3 in ovarian cancer remains unclear. In this study, we establish TUSC3 as a novel ovarian cancer tumor suppressor using a xenograft mouse model and demonstrate that loss of TUSC3 alters the molecular response to endoplasmic reticulum stress and induces hallmarks of the epithelial-to-mesenchymal transition in ovarian cancer cells. In summary, we have confirmed the tumor-suppressive function of TUSC3 and identified the possible mechanism driving TUSC3-deficient ovarian cancer cells toward a malignant phenotype.
© 2015 UICC.

Entities:  

Keywords:  N33; TUSC3; endoplasmic reticulum stress; epithelial-to-mesenchymal transition; ovarian cancer; tumor suppressor

Mesh:

Substances:

Year:  2015        PMID: 25735931     DOI: 10.1002/ijc.29502

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  20 in total

Review 1.  TUSC3: functional duality of a cancer gene.

Authors:  Kateřina Vašíčková; Peter Horak; Petr Vaňhara
Journal:  Cell Mol Life Sci       Date:  2017-09-19       Impact factor: 9.261

2.  TUSC3 suppresses glioblastoma development by inhibiting Akt signaling.

Authors:  Zhenfeng Jiang; Mian Guo; Xiangtong Zhang; Lifen Yao; Jia Shen; Guizhen Ma; Li Liu; Liwei Zhao; Chuncheng Xie; Hongsheng Liang; Haiyang Wang; Minwei Zhu; Li Hu; Yuanyuan Song; Hong Shen; Zhiguo Lin
Journal:  Tumour Biol       Date:  2016-05-13

3.  Effects of RNAi-mediated TUSC3 silencing on radiation-induced autophagy and radiation sensitivity of human lung adenocarcinoma cell line A549 under hypoxic condition.

Authors:  Ya-Guang Li; Nai-Xin Liang; Ying-Zhi Qin; Dong-Jie Ma; Chang-Jin Huang; Lei Liu; Shan-Qing Li
Journal:  Tumour Biol       Date:  2016-11-30

4.  Genome-wide association study evaluating single-nucleotide polymorphisms and outcomes in patients with advanced stage serous ovarian or primary peritoneal cancer: An NRG Oncology/Gynecologic Oncology Group study.

Authors:  Kathleen N Moore; David Tritchler; Kenneth M Kaufman; Heather Lankes; Michael C J Quinn; Linda Van Le; Andrew Berchuck; Floor J Backes; Krishnansu S Tewari; Roger B Lee; Joshua P Kesterson; Robert M Wenham; Deborah K Armstrong; Thomas C Krivak; Michael A Bookman; Michael J Birrer
Journal:  Gynecol Oncol       Date:  2017-09-19       Impact factor: 5.482

5.  Decreased TUSC3 Promotes Pancreatic Cancer Proliferation, Invasion and Metastasis.

Authors:  Xiaoqiang Fan; Xiu Zhang; Jie Shen; Haibin Zhao; Xuetao Yu; Yong'an Chen; Zhuonan Zhuang; Xiaolong Deng; Hua Feng; Yunfei Wang; Long Peng
Journal:  PLoS One       Date:  2016-02-12       Impact factor: 3.240

Review 6.  Regulation of EMT in Colorectal Cancer: A Culprit in Metastasis.

Authors:  Trung Vu; Pran K Datta
Journal:  Cancers (Basel)       Date:  2017-12-16       Impact factor: 6.639

Review 7.  TUSC3: a novel tumour suppressor gene and its functional implications.

Authors:  Xinshuang Yu; Chunjuan Zhai; Yujun Fan; Jiandong Zhang; Ning Liang; Fengjun Liu; Lili Cao; Jia Wang; Juan Du
Journal:  J Cell Mol Med       Date:  2017-03-08       Impact factor: 5.310

8.  Different Array CGH profiles within hereditary breast cancer tumors associated to BRCA1 expression and overall survival.

Authors:  Carolina Alvarez; Andrés Aravena; Teresa Tapia; Ester Rozenblum; Luisa Solís; Alejandro Corvalán; Mauricio Camus; Manuel Alvarez; David Munroe; Alejandro Maass; Pilar Carvallo
Journal:  BMC Cancer       Date:  2016-03-15       Impact factor: 4.430

9.  TUSC3 induces autophagy in human non-small cell lung cancer cells through Wnt/β-catenin signaling.

Authors:  Yun Peng; Jun Cao; Xiao-Yi Yao; Jian-Xin Wang; Mei-Zuo Zhong; Ping-Ping Gan; Jian-Huang Li
Journal:  Oncotarget       Date:  2017-05-08

10.  SOX2 regulates multiple malignant processes of breast cancer development through the SOX2/miR-181a-5p, miR-30e-5p/TUSC3 axis.

Authors:  Kuancan Liu; Fuan Xie; Anding Gao; Rui Zhang; Long Zhang; Zhangwu Xiao; Qiong Hu; Weifeng Huang; Qiaojia Huang; Baoshun Lin; Jian Zhu; Haikun Wang; Jianwen Que; Xiaopeng Lan
Journal:  Mol Cancer       Date:  2017-03-14       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.